A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma

This study aims to develop a reproducible rat model for post-traumatic bisphosphonate-related osteonecrosis of the jaw (BRONJ). In our previous studies using dental extraction as an inducing factor, only 30%-60% of zoledronate-treated animals fulfilled the definition of clinical BRONJ. We modified t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2015-07, Vol.10 (7), p.e0132520
Hauptverfasser: Howie, R Nicole, Borke, James L, Kurago, Zoya, Daoudi, Asma, Cray, James, Zakhary, Ibrahim E, Brown, Tara L, Raley, J Nathan, Tran, Loan T, Messer, Regina, Medani, Fardous, Elsalanty, Mohammed E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 7
container_start_page e0132520
container_title PloS one
container_volume 10
creator Howie, R Nicole
Borke, James L
Kurago, Zoya
Daoudi, Asma
Cray, James
Zakhary, Ibrahim E
Brown, Tara L
Raley, J Nathan
Tran, Loan T
Messer, Regina
Medani, Fardous
Elsalanty, Mohammed E
description This study aims to develop a reproducible rat model for post-traumatic bisphosphonate-related osteonecrosis of the jaw (BRONJ). In our previous studies using dental extraction as an inducing factor, only 30%-60% of zoledronate-treated animals fulfilled the definition of clinical BRONJ. We modified the zoledronate regimen and introduced repeated surgical extraction to illicit quantifiable BRONJ in all animals. Eighty retired-breeder female Sprague-Dawley rats were divided between the treatment (i.v. zoledronate; 80 μg/kg/week for 13 weeks) and control (saline) groups. On week 13, the left mandibular first molar was surgically extracted, followed by the second molar a week later. Animals were euthanized at 1-week, 2-weeks, and 8-weeks following extraction. The occurrence and severity of BRONJ were scored in each animal based on gross and MicroCT analysis. Parameters of bone formation and osteoclast functions at the extraction site were compared between groups. All zoledronate-treated animals developed a severe case of BRONJ that fulfilled the clinical definition of the condition in humans. Osteoclast attachment continued to be defective eight weeks after stopping the treatment. There were no signs of kidney or liver toxicity. Our data confirmed that repeated surgical extraction (major trauma) by itself consistently precipitated massive bone necrosis in ZA-treated animals, eliminating the need to induce pre-existing infection or comorbidity. These results will be the basis for further studies examining the in-vivo pathogenesis and prevention of BRONJ.
doi_str_mv 10.1371/journal.pone.0132520
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1698024335</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A422136957</galeid><doaj_id>oai_doaj_org_article_efdc28a7919d414bab30847d0a76e7ed</doaj_id><sourcerecordid>A422136957</sourcerecordid><originalsourceid>FETCH-LOGICAL-c718t-20f8bd38d552e84f17e8d3137f8ec2feb3515d1e991f65db946f0339b7db8a343</originalsourceid><addsrcrecordid>eNqNkl2L1DAYhYso7rr6D0QLguDFjPlo2vRmYVj8GNllYB298CakzZtOhrYZk9TRf2_G6S5TUJBeJLx5zml6epLkOUZzTAv8dmsH18t2vrM9zBGmhBH0IDnHJSWznCD68GR_ljzxfosQozzPHydnJMdxk7PzRCzSG6ugTbV16coHiG61s9741Oo0bCD9JPfp3oRN-s22oJztZYB07UCGDvoQdW1r96Zv0lvYxSGo9EZuo9nayaGTT5NHWrYeno3rRfLl_bv11cfZ9erD8mpxPasLzMOMIM0rRblijADPNC6AKxq_U3OoiYaKMswUhrLEOmeqKrNcI0rLqlAVlzSjF8nLo--utV6M2XiB85IjklHKIrE8EsrKrdg500n3S1hpxJ-BdY2QLpi6BQFa1YTLosSlynBWyYoinhUKySKHAlT0uhzfNlQdqDoG4WQ7MZ2e9GYjGvtDZAwxzvJo8Go0cPb7AD7848oj1ch4K9NrG83qzvhaLDJCMM1LVkRq_hcqPgo6U8f_qU2cTwRvJoLIBPgZGjl4L5afb_-fXX2dsq9P2A3INmy8bYdgbO-nYHYED03zDvR9chiJQ7nv0hCHcoux3FH24jT1e9Fdm-lvpD70yQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1698024335</pqid></control><display><type>article</type><title>A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Howie, R Nicole ; Borke, James L ; Kurago, Zoya ; Daoudi, Asma ; Cray, James ; Zakhary, Ibrahim E ; Brown, Tara L ; Raley, J Nathan ; Tran, Loan T ; Messer, Regina ; Medani, Fardous ; Elsalanty, Mohammed E</creator><contributor>Heymann, Dominique</contributor><creatorcontrib>Howie, R Nicole ; Borke, James L ; Kurago, Zoya ; Daoudi, Asma ; Cray, James ; Zakhary, Ibrahim E ; Brown, Tara L ; Raley, J Nathan ; Tran, Loan T ; Messer, Regina ; Medani, Fardous ; Elsalanty, Mohammed E ; Heymann, Dominique</creatorcontrib><description>This study aims to develop a reproducible rat model for post-traumatic bisphosphonate-related osteonecrosis of the jaw (BRONJ). In our previous studies using dental extraction as an inducing factor, only 30%-60% of zoledronate-treated animals fulfilled the definition of clinical BRONJ. We modified the zoledronate regimen and introduced repeated surgical extraction to illicit quantifiable BRONJ in all animals. Eighty retired-breeder female Sprague-Dawley rats were divided between the treatment (i.v. zoledronate; 80 μg/kg/week for 13 weeks) and control (saline) groups. On week 13, the left mandibular first molar was surgically extracted, followed by the second molar a week later. Animals were euthanized at 1-week, 2-weeks, and 8-weeks following extraction. The occurrence and severity of BRONJ were scored in each animal based on gross and MicroCT analysis. Parameters of bone formation and osteoclast functions at the extraction site were compared between groups. All zoledronate-treated animals developed a severe case of BRONJ that fulfilled the clinical definition of the condition in humans. Osteoclast attachment continued to be defective eight weeks after stopping the treatment. There were no signs of kidney or liver toxicity. Our data confirmed that repeated surgical extraction (major trauma) by itself consistently precipitated massive bone necrosis in ZA-treated animals, eliminating the need to induce pre-existing infection or comorbidity. These results will be the basis for further studies examining the in-vivo pathogenesis and prevention of BRONJ.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0132520</identifier><identifier>PMID: 26186665</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acid Phosphatase - metabolism ; Analysis ; Animals ; Auditory defects ; Biocompatibility ; Biomedical materials ; Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnostic imaging ; Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology ; Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology ; Bone disorder agents ; Bone growth ; Comorbidity ; Computed tomography ; Dentistry ; Diphosphonates - adverse effects ; Disease Models, Animal ; Drug dosages ; Female ; Imidazoles - adverse effects ; Infections ; Isoenzymes - metabolism ; Jaw ; Kidney - drug effects ; Kidney - pathology ; Kidneys ; Liver ; Liver - drug effects ; Liver - pathology ; Mandible ; Mandible - diagnostic imaging ; Mandible - drug effects ; Mandible - pathology ; Medicine ; Osteoclasts - drug effects ; Osteoclasts - pathology ; Osteogenesis ; Osteonecrosis ; Pathogenesis ; Rats ; Rats, Sprague-Dawley ; Rodents ; Studies ; Surgeons ; Surgery ; Systematic review ; Tartrate-Resistant Acid Phosphatase ; Tooth Extraction ; Toxicity ; Trauma ; Wound Healing - drug effects ; Wounds and Injuries - complications ; X-Ray Microtomography ; Zoledronic Acid</subject><ispartof>PloS one, 2015-07, Vol.10 (7), p.e0132520</ispartof><rights>COPYRIGHT 2015 Public Library of Science</rights><rights>2015 Howie et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 Howie et al 2015 Howie et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c718t-20f8bd38d552e84f17e8d3137f8ec2feb3515d1e991f65db946f0339b7db8a343</citedby><cites>FETCH-LOGICAL-c718t-20f8bd38d552e84f17e8d3137f8ec2feb3515d1e991f65db946f0339b7db8a343</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505856/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505856/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2095,2914,23846,27903,27904,53770,53772,79347,79348</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26186665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Heymann, Dominique</contributor><creatorcontrib>Howie, R Nicole</creatorcontrib><creatorcontrib>Borke, James L</creatorcontrib><creatorcontrib>Kurago, Zoya</creatorcontrib><creatorcontrib>Daoudi, Asma</creatorcontrib><creatorcontrib>Cray, James</creatorcontrib><creatorcontrib>Zakhary, Ibrahim E</creatorcontrib><creatorcontrib>Brown, Tara L</creatorcontrib><creatorcontrib>Raley, J Nathan</creatorcontrib><creatorcontrib>Tran, Loan T</creatorcontrib><creatorcontrib>Messer, Regina</creatorcontrib><creatorcontrib>Medani, Fardous</creatorcontrib><creatorcontrib>Elsalanty, Mohammed E</creatorcontrib><title>A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>This study aims to develop a reproducible rat model for post-traumatic bisphosphonate-related osteonecrosis of the jaw (BRONJ). In our previous studies using dental extraction as an inducing factor, only 30%-60% of zoledronate-treated animals fulfilled the definition of clinical BRONJ. We modified the zoledronate regimen and introduced repeated surgical extraction to illicit quantifiable BRONJ in all animals. Eighty retired-breeder female Sprague-Dawley rats were divided between the treatment (i.v. zoledronate; 80 μg/kg/week for 13 weeks) and control (saline) groups. On week 13, the left mandibular first molar was surgically extracted, followed by the second molar a week later. Animals were euthanized at 1-week, 2-weeks, and 8-weeks following extraction. The occurrence and severity of BRONJ were scored in each animal based on gross and MicroCT analysis. Parameters of bone formation and osteoclast functions at the extraction site were compared between groups. All zoledronate-treated animals developed a severe case of BRONJ that fulfilled the clinical definition of the condition in humans. Osteoclast attachment continued to be defective eight weeks after stopping the treatment. There were no signs of kidney or liver toxicity. Our data confirmed that repeated surgical extraction (major trauma) by itself consistently precipitated massive bone necrosis in ZA-treated animals, eliminating the need to induce pre-existing infection or comorbidity. These results will be the basis for further studies examining the in-vivo pathogenesis and prevention of BRONJ.</description><subject>Acid Phosphatase - metabolism</subject><subject>Analysis</subject><subject>Animals</subject><subject>Auditory defects</subject><subject>Biocompatibility</subject><subject>Biomedical materials</subject><subject>Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnostic imaging</subject><subject>Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology</subject><subject>Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology</subject><subject>Bone disorder agents</subject><subject>Bone growth</subject><subject>Comorbidity</subject><subject>Computed tomography</subject><subject>Dentistry</subject><subject>Diphosphonates - adverse effects</subject><subject>Disease Models, Animal</subject><subject>Drug dosages</subject><subject>Female</subject><subject>Imidazoles - adverse effects</subject><subject>Infections</subject><subject>Isoenzymes - metabolism</subject><subject>Jaw</subject><subject>Kidney - drug effects</subject><subject>Kidney - pathology</subject><subject>Kidneys</subject><subject>Liver</subject><subject>Liver - drug effects</subject><subject>Liver - pathology</subject><subject>Mandible</subject><subject>Mandible - diagnostic imaging</subject><subject>Mandible - drug effects</subject><subject>Mandible - pathology</subject><subject>Medicine</subject><subject>Osteoclasts - drug effects</subject><subject>Osteoclasts - pathology</subject><subject>Osteogenesis</subject><subject>Osteonecrosis</subject><subject>Pathogenesis</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Rodents</subject><subject>Studies</subject><subject>Surgeons</subject><subject>Surgery</subject><subject>Systematic review</subject><subject>Tartrate-Resistant Acid Phosphatase</subject><subject>Tooth Extraction</subject><subject>Toxicity</subject><subject>Trauma</subject><subject>Wound Healing - drug effects</subject><subject>Wounds and Injuries - complications</subject><subject>X-Ray Microtomography</subject><subject>Zoledronic Acid</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl2L1DAYhYso7rr6D0QLguDFjPlo2vRmYVj8GNllYB298CakzZtOhrYZk9TRf2_G6S5TUJBeJLx5zml6epLkOUZzTAv8dmsH18t2vrM9zBGmhBH0IDnHJSWznCD68GR_ljzxfosQozzPHydnJMdxk7PzRCzSG6ugTbV16coHiG61s9741Oo0bCD9JPfp3oRN-s22oJztZYB07UCGDvoQdW1r96Zv0lvYxSGo9EZuo9nayaGTT5NHWrYeno3rRfLl_bv11cfZ9erD8mpxPasLzMOMIM0rRblijADPNC6AKxq_U3OoiYaKMswUhrLEOmeqKrNcI0rLqlAVlzSjF8nLo--utV6M2XiB85IjklHKIrE8EsrKrdg500n3S1hpxJ-BdY2QLpi6BQFa1YTLosSlynBWyYoinhUKySKHAlT0uhzfNlQdqDoG4WQ7MZ2e9GYjGvtDZAwxzvJo8Go0cPb7AD7848oj1ch4K9NrG83qzvhaLDJCMM1LVkRq_hcqPgo6U8f_qU2cTwRvJoLIBPgZGjl4L5afb_-fXX2dsq9P2A3INmy8bYdgbO-nYHYED03zDvR9chiJQ7nv0hCHcoux3FH24jT1e9Fdm-lvpD70yQ</recordid><startdate>20150717</startdate><enddate>20150717</enddate><creator>Howie, R Nicole</creator><creator>Borke, James L</creator><creator>Kurago, Zoya</creator><creator>Daoudi, Asma</creator><creator>Cray, James</creator><creator>Zakhary, Ibrahim E</creator><creator>Brown, Tara L</creator><creator>Raley, J Nathan</creator><creator>Tran, Loan T</creator><creator>Messer, Regina</creator><creator>Medani, Fardous</creator><creator>Elsalanty, Mohammed E</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20150717</creationdate><title>A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma</title><author>Howie, R Nicole ; Borke, James L ; Kurago, Zoya ; Daoudi, Asma ; Cray, James ; Zakhary, Ibrahim E ; Brown, Tara L ; Raley, J Nathan ; Tran, Loan T ; Messer, Regina ; Medani, Fardous ; Elsalanty, Mohammed E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c718t-20f8bd38d552e84f17e8d3137f8ec2feb3515d1e991f65db946f0339b7db8a343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acid Phosphatase - metabolism</topic><topic>Analysis</topic><topic>Animals</topic><topic>Auditory defects</topic><topic>Biocompatibility</topic><topic>Biomedical materials</topic><topic>Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnostic imaging</topic><topic>Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology</topic><topic>Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology</topic><topic>Bone disorder agents</topic><topic>Bone growth</topic><topic>Comorbidity</topic><topic>Computed tomography</topic><topic>Dentistry</topic><topic>Diphosphonates - adverse effects</topic><topic>Disease Models, Animal</topic><topic>Drug dosages</topic><topic>Female</topic><topic>Imidazoles - adverse effects</topic><topic>Infections</topic><topic>Isoenzymes - metabolism</topic><topic>Jaw</topic><topic>Kidney - drug effects</topic><topic>Kidney - pathology</topic><topic>Kidneys</topic><topic>Liver</topic><topic>Liver - drug effects</topic><topic>Liver - pathology</topic><topic>Mandible</topic><topic>Mandible - diagnostic imaging</topic><topic>Mandible - drug effects</topic><topic>Mandible - pathology</topic><topic>Medicine</topic><topic>Osteoclasts - drug effects</topic><topic>Osteoclasts - pathology</topic><topic>Osteogenesis</topic><topic>Osteonecrosis</topic><topic>Pathogenesis</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Rodents</topic><topic>Studies</topic><topic>Surgeons</topic><topic>Surgery</topic><topic>Systematic review</topic><topic>Tartrate-Resistant Acid Phosphatase</topic><topic>Tooth Extraction</topic><topic>Toxicity</topic><topic>Trauma</topic><topic>Wound Healing - drug effects</topic><topic>Wounds and Injuries - complications</topic><topic>X-Ray Microtomography</topic><topic>Zoledronic Acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Howie, R Nicole</creatorcontrib><creatorcontrib>Borke, James L</creatorcontrib><creatorcontrib>Kurago, Zoya</creatorcontrib><creatorcontrib>Daoudi, Asma</creatorcontrib><creatorcontrib>Cray, James</creatorcontrib><creatorcontrib>Zakhary, Ibrahim E</creatorcontrib><creatorcontrib>Brown, Tara L</creatorcontrib><creatorcontrib>Raley, J Nathan</creatorcontrib><creatorcontrib>Tran, Loan T</creatorcontrib><creatorcontrib>Messer, Regina</creatorcontrib><creatorcontrib>Medani, Fardous</creatorcontrib><creatorcontrib>Elsalanty, Mohammed E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Howie, R Nicole</au><au>Borke, James L</au><au>Kurago, Zoya</au><au>Daoudi, Asma</au><au>Cray, James</au><au>Zakhary, Ibrahim E</au><au>Brown, Tara L</au><au>Raley, J Nathan</au><au>Tran, Loan T</au><au>Messer, Regina</au><au>Medani, Fardous</au><au>Elsalanty, Mohammed E</au><au>Heymann, Dominique</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2015-07-17</date><risdate>2015</risdate><volume>10</volume><issue>7</issue><spage>e0132520</spage><pages>e0132520-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>This study aims to develop a reproducible rat model for post-traumatic bisphosphonate-related osteonecrosis of the jaw (BRONJ). In our previous studies using dental extraction as an inducing factor, only 30%-60% of zoledronate-treated animals fulfilled the definition of clinical BRONJ. We modified the zoledronate regimen and introduced repeated surgical extraction to illicit quantifiable BRONJ in all animals. Eighty retired-breeder female Sprague-Dawley rats were divided between the treatment (i.v. zoledronate; 80 μg/kg/week for 13 weeks) and control (saline) groups. On week 13, the left mandibular first molar was surgically extracted, followed by the second molar a week later. Animals were euthanized at 1-week, 2-weeks, and 8-weeks following extraction. The occurrence and severity of BRONJ were scored in each animal based on gross and MicroCT analysis. Parameters of bone formation and osteoclast functions at the extraction site were compared between groups. All zoledronate-treated animals developed a severe case of BRONJ that fulfilled the clinical definition of the condition in humans. Osteoclast attachment continued to be defective eight weeks after stopping the treatment. There were no signs of kidney or liver toxicity. Our data confirmed that repeated surgical extraction (major trauma) by itself consistently precipitated massive bone necrosis in ZA-treated animals, eliminating the need to induce pre-existing infection or comorbidity. These results will be the basis for further studies examining the in-vivo pathogenesis and prevention of BRONJ.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>26186665</pmid><doi>10.1371/journal.pone.0132520</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2015-07, Vol.10 (7), p.e0132520
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1698024335
source MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS); EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Acid Phosphatase - metabolism
Analysis
Animals
Auditory defects
Biocompatibility
Biomedical materials
Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnostic imaging
Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology
Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology
Bone disorder agents
Bone growth
Comorbidity
Computed tomography
Dentistry
Diphosphonates - adverse effects
Disease Models, Animal
Drug dosages
Female
Imidazoles - adverse effects
Infections
Isoenzymes - metabolism
Jaw
Kidney - drug effects
Kidney - pathology
Kidneys
Liver
Liver - drug effects
Liver - pathology
Mandible
Mandible - diagnostic imaging
Mandible - drug effects
Mandible - pathology
Medicine
Osteoclasts - drug effects
Osteoclasts - pathology
Osteogenesis
Osteonecrosis
Pathogenesis
Rats
Rats, Sprague-Dawley
Rodents
Studies
Surgeons
Surgery
Systematic review
Tartrate-Resistant Acid Phosphatase
Tooth Extraction
Toxicity
Trauma
Wound Healing - drug effects
Wounds and Injuries - complications
X-Ray Microtomography
Zoledronic Acid
title A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T23%3A09%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Model%20for%20Osteonecrosis%20of%20the%20Jaw%20with%20Zoledronate%20Treatment%20following%20Repeated%20Major%20Trauma&rft.jtitle=PloS%20one&rft.au=Howie,%20R%20Nicole&rft.date=2015-07-17&rft.volume=10&rft.issue=7&rft.spage=e0132520&rft.pages=e0132520-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0132520&rft_dat=%3Cgale_plos_%3EA422136957%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1698024335&rft_id=info:pmid/26186665&rft_galeid=A422136957&rft_doaj_id=oai_doaj_org_article_efdc28a7919d414bab30847d0a76e7ed&rfr_iscdi=true